European consensus-based recommendations for the diagnosis and treatment of rare paediatric vasculitides - the SHARE initiative.

SHARE recommendations Takayasu arteritis childhood/paediatric eosinophilic granulomatosis with polyangiitis granulomatosis with polyangiitis microscopic polyangiitis polyarteritis nodosa systemic vasculitis treatment

Journal

Rheumatology (Oxford, England)
ISSN: 1462-0332
Titre abrégé: Rheumatology (Oxford)
Pays: England
ID NLM: 100883501

Informations de publication

Date de publication:
01 04 2019
Historique:
received: 02 07 2018
accepted: 04 09 2018
pubmed: 12 12 2018
medline: 31 1 2020
entrez: 12 12 2018
Statut: ppublish

Résumé

The European initiative Single Hub and Access point for paediatric Rheumatology in Europe (SHARE) aimed to optimize care for children with rheumatic diseases. Systemic vasculitides are very rare in children. Consequently, despite recent advances, paediatric-specific information is sparse. The lack of evidence-based recommendations is an important, unmet need. This study aimed to provide recommendations for diagnosing and treating children with rare forms of childhood systemic vasculitis. Recommendations were developed by a consensus process in accordance with the European League Against Rheumatism standard operating procedures. A systematic literature review informed the recommendations, which were devised and evaluated by a panel of experts via an online survey, and two consensus meetings using nominal group technique. Recommendations were accepted when ⩾ 80% of experts agreed. Ninety-three relevant articles were found, and 78 recommendations were accepted in the two consensus meetings. General, cross-cutting recommendations and disease-specific statements regarding the diagnosis and treatment of childhood-onset PAN, granulomatosis with polyangiitis, microscopic polyangiitis, eosinophilic granulomatosis with polyangiitis, and Takayasu arteritis are provided. These Single Hub and Access point for paediatric Rheumatology in Europe recommendations were formulated through an evidence-based consensus process to support uniform, high-quality standard of care for children with rare forms of paediatric systemic vasculitis.

Identifiants

pubmed: 30535249
pii: 5232680
doi: 10.1093/rheumatology/key322
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

656-671

Commentaires et corrections

Type : ErratumIn

Informations de copyright

© The Author(s) 2018. Published by Oxford University Press on behalf of the British Society for Rheumatology. All rights reserved. For permissions, please email: journals.permissions@oup.com.

Auteurs

Nienke de Graeff (N)

Department of Paediatric Rheumatology, Wilhelmina Children's Hospital, Utrecht.

Noortje Groot (N)

Department of Paediatric Rheumatology, Wilhelmina Children's Hospital, Utrecht.
Department of Paediatric Rheumatology, Sophia Children's Hospital, Erasmus Medical Centre, Rotterdam, The Netherlands.
Department of Paediatric Rheumatology, Alder Hey Children's Hospital, Liverpool.

Paul Brogan (P)

Department of Paediatric Rheumatology, University College London Great Ormond Street Institute of Child Health and Great Ormond St Hospital for Children NHS Foundation Trust, London, UK.

Seza Ozen (S)

Department of Paediatric Rheumatology, Hacettepe University, Ankara, Turkey.

Tadej Avcin (T)

Department of Paediatric Rheumatology, University Children's Hospital Ljubljana, Ljubljana, Slovenia.

Brigitte Bader-Meunier (B)

Department of Paediatric Rheumatology, Necker Hospital, Assistance Publique-Hôpitaux de Paris, Paris, France.

Pavla Dolezalova (P)

1st Faculty of Medicine, Charles University and General University Hospital, Prague, Czech Republic.

Brian M Feldman (BM)

Department of Paediatric Rheumatology, The Hospital for Sick Children, University of Toronto, Toronto, Canada.

Isabelle Kone-Paut (I)

Department of Paediatric Rheumatology, Bicêtre University Hospital, APHP, University of Paris Sud, Paris, France.

Pekka Lahdenne (P)

Department of Paediatric Rheumatology, Hospital for Children and Adolescents, University of Helsinki, Helsinki, Finland.

Stephen D Marks (SD)

Department of Paediatric Rheumatology, University College London Great Ormond Street Institute of Child Health and Great Ormond St Hospital for Children NHS Foundation Trust, London, UK.

Liza McCann (L)

Department of Paediatric Rheumatology, Alder Hey Children's Hospital, Liverpool.

Clarissa Pilkington (C)

Department of Paediatric Rheumatology, University College London Great Ormond Street Institute of Child Health and Great Ormond St Hospital for Children NHS Foundation Trust, London, UK.

Angelo Ravelli (A)

Department of Paediatric Rheumatology, Gaslini Children's Hospital, Genoa, Italy.

Annet van Royen (A)

Department of Paediatric Rheumatology, Wilhelmina Children's Hospital, Utrecht.

Yosef Uziel (Y)

Meir Medical Center, Kfar Saba, Tel Aviv University, Sackler School of Medicine, Tel Aviv, Israel.

Bas Vastert (B)

Department of Paediatric Rheumatology, Wilhelmina Children's Hospital, Utrecht.

Nico Wulffraat (N)

Department of Paediatric Rheumatology, Wilhelmina Children's Hospital, Utrecht.

Sylvia Kamphuis (S)

Department of Paediatric Rheumatology, Sophia Children's Hospital, Erasmus Medical Centre, Rotterdam, The Netherlands.

Michael W Beresford (MW)

Department of Paediatric Rheumatology, Alder Hey Children's Hospital, Liverpool.
Institute of Translational Medicine, University of Liverpool, Liverpool, UK.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH